1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
SonoScape Medical Corp.

SonoScape Medical Corp.

300633.SZ
SonoScape Medical Corp.CN flagShenzhen Stock Exchange
18.63
CNY
-0.97
- -
7.91BMarket Cap
SonoScape Medical Corp.
300633.SZ
(Shenzhen Stock Exchange)

Recent

price

18.63

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
1.8
1.88
1.99
2.55
3.06
3.09
3.02
3.62
4.1
4.95
4.67
5.38
4.55
Revenue per Share
- -
- -
0.37
0.29
0.36
0.49
0.63
0.25
-0.12
0.62
0.86
1.06
0.33
0.46
0.04
Basic EPS, GAAP
- -
- -
0.27
0.11
0.34
0.24
0.38
0.08
0.3
0.38
0.66
0.73
0.23
-0.44
-0.38
Free Cash Flow per Basic Share
- -
- -
0.18
0.01
0.01
0.04
0.05
0.11
0.08
0.01
0.13
0.19
0.33
0.11
0.12
Dividend per Share
- -
- -
1.07
1.3
1.63
2.03
2.47
2.61
2.6
3.14
3.56
4.34
4.28
4.66
4.28
Book Value per Share
- -
- -
0.83
1.13
1.55
2.36
2.04
2.28
2.55
5.09
5.6
6.57
6.58
7.02
6.61
Tangible Book Value per Share
- -
- -
356
365
362
388
401
406
386
399
430
429
432
429
432
Basic Weighted Avg Shares
484
592
640
686
719
989
1,227
1,254
1,163
1,445
1,763
2,120
2,014
2,309
1,965
Sales/Revenue/Turnover
25.89
25.05
20.52
11.88
12.25
22.57
22.5
11.05
17.34
22.09
23.15
23.98
9.84
7.99
1.82
Operating Margin (%)
5
10
12
14
16
15
19
25
29
54
53
66
86
103
- -
Depreciation Expense
130
71
132
106
130
190
253
102
-46
247
370
454
142
197
19
Net Income, GAAP
13.84
19.69
9.58
10.59
7.19
8.49
6.9
5.72
- -
2.74
3.18
4.09
- -
- -
- -
Effective Tax Rate (%)
26.83
11.93
20.6
15.44
18.13
19.21
20.59
8.1
-3.98
17.12
20.98
21.43
7.07
8.54
0.96
Profit Margin (%)
199
285
371
489
551
869
677
850
652
1,576
1,765
2,057
1,892
1,796
1,816
Working Capital
25
25
73
58
- -
- -
18
256
67
69
27
34
76
65
69
LT Debt
352
365
445
566
720
1,059
1,311
1,404
1,345
2,355
2,740
3,146
3,108
3,262
3,116
Total Equity
- -
26.59
21.65
10.53
11
22.14
20.17
7.87
- -
14.73
14.86
16.11
- -
- -
- -
Return on Invested Capital (%)
- -
18.36
27.79
18.02
20.84
26.19
25.63
8.65
- -
17.76
24.01
24.96
- -
- -
- -
Return on Capital (%)
- -
22.68
36.92
24.71
24.47
27.6
28.41
9.89
-4.49
21.95
26.6
26.82
7.69
10.26
1.01
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
279
130
199
LT Borrowings
40
40
40
LT Finance Leases
36
35
29
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
433
433
433
Market Capitalization
12,660
12,570
12,833

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
2,975
2,646
2,604
Cash, Cash Equivalents & STI
2,009
1,528
1,513
Accounts Receivable, Net
212
251
190
Inventories
653
760
788
Total Current Liabilities
1,083
750
788
Payables & Accruals
- -
- -
- -
ST Debt
279
130
199
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
21.1%
22%
4.96%
Free Cash Flow
20.4%
-46.12%
-290.78%
Net Income, GAAP
-69.57%
-118.42%
38.54%
Sales/Revenue/Turnover
13.75%
15.23%
14.65%
Total Cash Common Dividend
128.39%
182.15%
-67.28%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
479
533
386
616
2,014
2025
430
534
850
- -
2,309
2026
481
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.23
- -
- -
- -
0.33
2025
0.02
- -
- -
- -
0.46
2026
-0.03
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.33
2025
- -
- -
- -
- -
0.11
2026
- -
- -
- -
- -
- -
Similar Companies
Acarix AB (publ) (ACIXF)
Titan Medical Inc. (TMDI)
Medtronic plc (MDT)
INVO Fertility, Inc. (IVF)
i-SENS Inc (099190.KS)
TaiDoc Technology Corporation (4736.TW)
Business
SonoScape Medical Corp. (300633.SZ) develops, manufactures and sells medical diagnostic and treatment equipment with a focus on ultrasound imaging, endoscopy, minimally invasive surgery and cardiovascular intervention products. The company offers trolley and portable color Doppler ultrasound systems, black-and-white ultrasound systems, veterinary ultrasound equipment including the ProPet series, transducers; high-definition endoscopy systems such as the HD-500, HD-550, HD-580 and iEndo platforms with gastroscopes, colonoscopes, bronchoscopes, duodenoscopes, endoscopic ultrasound scopes; minimally invasive surgical products including laparoscopes, thoracoscopes, hysteroscopes, arthroscopes; cardiovascular interventional products such as the V20 Series intravascular ultrasound platform; and related image processors, light sources, camera systems and peripheral equipment for applications in radiology, OB/GYN, MSK, vascular, urology, pulmonology, gastroenterology and veterinary care. Founded in 2002 and headquartered in Shenzhen, China, SonoScape operates branch offices in 30 major cities across China and maintains global R&D centers in Shenzhen, Shanghai, Wuhan, Tuttlingen, Tokyo, San Francisco and Seattle, serving customers in over 170 countries and regions. Recent developments include the launch of the P80 Elite series for women's care, ProPet 80/70/60 veterinary ultrasound systems, S-Fetus 4.0 obstetric software, SV-M4K220 4K 3D fluorescence endoscopy platform, multiple products gaining EU-MDR CE-Mark certification, recognition as a National Enterprise Technology Center, CNAS laboratory accreditation and collaboration with OrbusNeich on intravascular ultrasound distribution.